<div id="readability-page-1">We recently compiled a list of the 7 Most Promising Gene Editing Stocks According to Analysts. 10x Genomics, Inc. is one of the seven stocks on our list of most promising stocks. On December 15, 2025, Barclays analyst Luke Sergott raised the price target for TXG from $17 to $22 while maintaining an Overweight rating, reflecting […]</div>

<p>巴克萊分析師盧克·塞爾戈特將 10X Genomics, Inc. (TXG) 的目標價從 17 美元上調至 22 美元，同時維持 “增持” 評級，儘管研究支出不均</p>

儘管研究支出不均衡，巴克萊對 10X Genomics, Inc. (TXG) 的看法變得更加樂觀